Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency through Suppression of Erythroid Heme Synthesis

  • Rochus A Neeleman
  • , Eduard J van Beers
  • , Edith C Friesema
  • , Rita Koole-Lesuis
  • , Willem L van der Pol
  • , J H Paul Wilson
  • , Janneke G Langendonk

Research output: Contribution to journalEditorialAcademicpeer-review

8 Downloads (Pure)

Abstract

We present a case of delta-aminolevulinic acid dehydratase-porphyria (ADP) who was successfully treated by suppressing bone-marrow production of toxic heme precursors. Together with supporting evidence from earlier cases, it is likely ADP has both hepatic and erythroid origins. This article is protected by copyright. All rights reserved.

Original languageEnglish
Pages (from-to)434-436
Number of pages3
JournalHepatology (Baltimore, Md.)
Volume70
Issue number1
Early online date6 Feb 2019
DOIs
Publication statusPublished - Jul 2019

Fingerprint

Dive into the research topics of 'Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency through Suppression of Erythroid Heme Synthesis'. Together they form a unique fingerprint.

Cite this